Literature DB >> 1533979

The E3-14.5K integral membrane protein of adenovirus that is required for down-regulation of the EGF receptor and for prevention of TNF cytolysis is O-glycosylated but not N-glycosylated.

P Krajcsi1, A E Tollefson, W S Wold.   

Abstract

The adenovirus E3-14.5K protein is a cytoplasmic integral membrane protein that functions in concert with the E3-10.4K protein to down-regulate the epidermal growth factor receptor and to prevent tumor necrosis factor cytolysis in adenovirus-infected cells. The 14.5K protein migrates as multiple bands in SDS-PAGE, indicating that it undergoes post-translational modification. The 14.5K protein is known to be phosphorylated on serine. We show here that 14.5K can be metabolically labeled with [3H]glucosamine, that the label is labile to alkali, and that the SDS-PAGE band pattern is simplified in a cell line that is defective in O-glycosylation. Thus, 14.5K is O-glycosylated, probably at a single site in the NH2-terminal lumenal domain. The protein was not metabolically labeled with [3H]mannose, and its SDS-PAGE band pattern was not affected by tunicamycin treatment in vivo or endo F treatment in vitro; thus, 14.5K is not N-glycosylated. There was no evidence that the 10.4K protein is glycosylated, and the 10.4K protein was not required for glycosylation of 14.5K. Virtually all 14.5K molecules appear to contain the core disaccharide Gal beta 1-3GalNAc alpha 1-Ser/Thr which is commonly found on mucin-type O-glycoproteins, and neuraminidase digestion experiments indicated that this disaccharide contains terminal sialic acid.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1533979     DOI: 10.1016/0042-6822(92)90511-m

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Adenovirus E3-6.7K protein is required in conjunction with the E3-RID protein complex for the internalization and degradation of TRAIL receptor 2.

Authors:  Drew L Lichtenstein; Konstantin Doronin; Karoly Toth; Mohan Kuppuswamy; William S M Wold; Ann E Tollefson
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

2.  The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis.

Authors:  J Shisler; C Yang; B Walter; C F Ware; L R Gooding
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Adenovirus RIDbeta subunit contains a tyrosine residue that is critical for RID-mediated receptor internalization and inhibition of Fas- and TRAIL-induced apoptosis.

Authors:  Drew L Lichtenstein; Peter Krajcsi; David J Esteban; Ann E Tollefson; William S M Wold
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes.

Authors:  T Dimitrov; P Krajcsi; T W Hermiston; A E Tollefson; M Hannink; W S Wold
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

5.  Distinct domains in the adenovirus E3 RIDalpha protein are required for degradation of Fas and the epidermal growth factor receptor.

Authors:  Tom A Zanardi; Soonpin Yei; Drew L Lichtenstein; Ann E Tollefson; William S M Wold
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

6.  The adenovirus E3 10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor, are localized in the plasma membrane.

Authors:  A R Stewart; A E Tollefson; P Krajcsi; S P Yei; W S Wold
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

Review 7.  Immunomodulatory functions encoded by the E3 transcription unit of adenoviruses.

Authors:  H G Burgert; J H Blusch
Journal:  Virus Genes       Date:  2000       Impact factor: 2.198

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.